Loading...
Careteq Limited
CTQ.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.01
A$0.00(0.00%)
Careteq Limited (CTQ.AX) Financial Performance & Income Statement Overview
Review Careteq Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
30.93%
↑ 30.93%
Operating Income Growth
47.41%
↑ 47.41%
Net Income Growth
38.45%
↑ 38.45%
Operating Cash Flow Growth
48.72%
↑ 48.72%
Operating Margin
-5.60%
↓ 5.60%
Gross Margin
55.75%
↑ 55.75%
Net Profit Margin
-12.74%
↓ 12.74%
ROE
-61.91%
↓ 61.91%
ROIC
-17.04%
↓ 17.04%
Careteq Limited (CTQ.AX) Income Statement & Financial Overview
Review Careteq Limited's (CTQ.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.08M | $4.15M | $3.12M | $1.90M |
| Cost of Revenue | $0.00 | $3.96M | $4.21M | $1.95M |
| Gross Profit | $3.08M | $196849.00 | -$1.09M | -$53102.00 |
| Gross Profit Ratio | $1.00 | $0.05 | -$0.35 | -$0.03 |
| R&D Expenses | $0.00 | $46715.00 | $58946.00 | $29473.00 |
| SG&A Expenses | $3.61M | $609073.00 | $558783.00 | $310824.00 |
| Operating Expenses | $3.61M | $609073.00 | $617729.00 | $701336.00 |
| Total Costs & Expenses | $3.90M | $4.57M | $4.83M | $2.65M |
| Interest Income | $0.00 | $0.00 | $6374.00 | $6374.00 |
| Interest Expense | $18900.00 | $89598.00 | $12748.00 | $0.00 |
| Depreciation & Amortization | $283731.00 | $203216.00 | $253576.00 | $89720.00 |
| EBITDA | -$420606.00 | -$777508.00 | -$1.85M | -$664719.00 |
| EBITDA Ratio | -$0.14 | -$0.05 | -$0.47 | -$0.35 |
| Operating Income | -$819650.00 | -$412220.00 | -$1.71M | -$754439.00 |
| Operating Income Ratio | -$0.27 | -$0.10 | -$0.55 | -$0.40 |
| Other Income/Expenses (Net) | $490055.00 | -$658104.00 | -$407199.00 | -$6374.00 |
| Income Before Tax | -$329595.00 | -$1.07M | -$2.11M | -$760813.00 |
| Income Before Tax Ratio | -$0.11 | -$0.26 | -$0.68 | -$0.40 |
| Income Tax Expense | $439031.00 | -$108650.00 | -$428271.00 | $82530.00 |
| Net Income | -$751315.00 | -$1.14M | -$1.90M | -$947616.00 |
| Net Income Ratio | -$0.24 | -$0.28 | -$0.61 | -$0.50 |
| EPS | -$0.01 | -$0.006 | -$0.01 | -$0.008 |
| Diluted EPS | -$0.01 | -$0.006 | -$0.01 | -$0.008 |
| Weighted Avg Shares Outstanding | $125.22M | $197.56M | $141.54M | $123.58M |
| Weighted Avg Shares Outstanding (Diluted) | $125.22M | $197.56M | $141.54M | $123.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan